Regeneron buys bankrupt 23andMe for $256m
23andMe has found itself a buyer after biotech Regeneron won an auction to buy the bankrupt genetics company for $256m. As …
23andMe has found itself a buyer after biotech Regeneron won an auction to buy the bankrupt genetics company for $256m. As …
Innovative Health has been awarded $147m in damages from a lawsuit against Biosense Webster relating to the Johnson & Johnson …
Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the …
A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather …
Once niche, the field of neuromodulation is now accelerating toward real-world breakthroughs for conditions such as tinnitus, substance use disorder, …
Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke monitoring, which also concurrently measures …
British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an "aggressive" new M&A strategy. Huma …
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio …
GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology, as …
Shares in STAAR Surgical jumped today (16 May) after the implantable lens developer revealed plans to bring $30m worth of …
Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT [optical coherence tomography] platform, allowing the company …
OncoHost has secured a €2.5m ($2.8m) grant from the EIC Transition Programme, an initiative under the EU’s broader Horizon Europe …
Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) technology use is linked to a significant …
AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, identifying suitable patients …
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence …